Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Transcatheter or Surgical Treatment of Aortic-Valve Stenosis

Blankenberg, Stefan, Seiffert, Moritz, Vonthein, Reinhard, Baumgartner, Helmut, Bleiziffer, Sabine, Borger, Michael A., Choi, Yeong-Hoon, Clemmensen, Peter, Cremer, Jochen, Czerny, Martin, Diercks, Nina, Eitel, Ingo, Ensminger, Stephan, Frank, Derk, Frey, Norbert, Hagendorff, Andreas, Hagl, Christian, Hamm, Christian, Kappert, Utz, Karck, Matthias, Kim, Won-Keun, König, Inke R., Krane, Markus, Landmesser, Ulf, Linke, Axel, Maier, Lars S., Massberg, Steffen, Neumann, Franz-Josef, Reichenspurner, Hermann, Rudolph, Tanja K., Schmid, Christof, Thiele, Holger, Twerenbold, Raphael, Walther, Thomas, Westermann, Dirk, Xhepa, Erion, Ziegler, Andreas, Falk, Volkmar·2024·New England Journal of Medicine

Abstract

BACKGROUND: Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lacking on the appropriate treatment strategy in routine clinical practice. METHODS: In this randomized noninferiority trial conducted at 38 sites in Germany, we assigned patients with severe aortic stenosis who were at low or intermediate surgical risk to undergo either TAVI or SAVR. Percutaneous- and surgical-valve prostheses were selected according to operator discretion. The primary outcome was a composite of death from any cause or fatal or nonfatal stroke at 1 year. RESULTS: A total of 1414 patients underwent randomization (701 to the TAVI group and 713 to the SAVR group). The mean (±SD) age of the patients was 74±4 years; 57% were men, and the median Society of Thoracic Surgeons risk score was 1.8% (low surgical risk). The Kaplan-Meier estimate of the primary outcome at 1 year was 5.4% in the TAVI group and 10.0% in the SAVR group (hazard ratio for death or stroke, 0.53; 95% confidence interval [CI], 0.35 to 0.79; P<0.001 for noninferiority). The incidence of death from any cause was 2.6% in the TAVI group and 6.2% in the SAVR group (hazard ratio, 0.43; 95% CI, 0.24 to 0.73); the incidence of stroke was 2.9% and 4.7%, respectively (hazard ratio, 0.61; 95% CI, 0.35 to 1.06). Procedural complications occurred in 1.5% and 1.0% of patients in the TAVI and SAVR groups, respectively. CONCLUSIONS: Among patients with severe aortic stenosis at low or intermediate surgical risk, TAVI was noninferior to SAVR with respect to death from any cause or stroke at 1 year. (Funded by the German Center for Cardiovascular Research and the German Heart Foundation; DEDICATE-DZHK6 ClinicalTrials.gov number, NCT03112980.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2400685

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 260

Metadata

Authors
Blankenberg, S., Seiffert, M., Vonthein, R., Baumgartner, H., Bleiziffer, S., Borger, M. A., Choi, Y.-H., Clemmensen, P., Cremer, J., Czerny, M., Diercks, N., Eitel, I., Ensminger, S., Frank, D., Frey, N., Hagendorff, A., Hagl, C., Hamm, C., Kappert, U., Karck, M., Kim, W.-K., König, I. R., Krane, M., Landmesser, U., Linke, A., Maier, L. S., Massberg, S., Neumann, F.-J., Reichenspurner, H., Rudolph, T. K., Schmid, C., Thiele, H., Twerenbold, R., Walther, T., Westermann, D., Xhepa, E., Ziegler, A., & Falk, V.
Venue
New England Journal of Medicine
Published
2024-05-02
Volume
390
Issue
17
Pages
1572-1583
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4394567510
Cited by
260
References
18
FWCI
69.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcatheter or Surgical Treatment of Aortic-Valve Stenosis. https://app.cochat.ai/papers/10.1056/nejmoa2400685
The paper
Blankenberg, S., Seiffert, M., Vonthein, R., Baumgartner, H., Bleiziffer, S., Borger, M. A., Choi, Y.-H., Clemmensen, P., Cremer, J., Czerny, M., Diercks, N., Eitel, I., Ensminger, S., Frank, D., Frey, N., Hagendorff, A., Hagl, C., Hamm, C., Kappert, U., . . . Falk, V. (2024). Transcatheter or Surgical Treatment of Aortic-Valve Stenosis. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2400685

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.